Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
fludarabine adenosine deaminase NA Successful target TTD , DGIDB Chronic Lymphocytic Leukemia[MeSHID:D015451]
Disease[MeSHID:D004194]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hematologic Neoplasms[MeSHID:D019337]		 0.27 approved unknown
fludarabine deoxycytidine kinase small molecule NA drugbank , DGIDB Chronic Lymphocytic Leukemia[MeSHID:D015451]
Disease[MeSHID:D004194]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hematologic Neoplasms[MeSHID:D019337]		 1.16 approved agonist
fludarabine dna polymerase alpha catalytic subunit small molecule NA drugbank , DGIDB Chronic Lymphocytic Leukemia[MeSHID:D015451]
Disease[MeSHID:D004194]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hematologic Neoplasms[MeSHID:D019337]		 3.18 approved inhibitor
fludarabine ribonucleoside-diphosphate reductase large subunit small molecule NA drugbank , DGIDB Chronic Lymphocytic Leukemia[MeSHID:D015451]
Disease[MeSHID:D004194]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hematologic Neoplasms[MeSHID:D019337]		 1.59 approved inhibitor
fludarabine dna small molecule NA drugbank Chronic Lymphocytic Leukemia[MeSHID:D015451]
Disease[MeSHID:D004194]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hematologic Neoplasms[MeSHID:D019337]		 NA approved incorporation into and destabilization
click here to return to the previous page